11-110456995-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004109.5(FDX1):āc.388A>Gā(p.Ile130Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000922 in 1,613,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004109.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FDX1 | NM_004109.5 | c.388A>G | p.Ile130Val | missense_variant | 3/4 | ENST00000260270.3 | NP_004100.1 | |
FDX1 | XM_047426566.1 | c.211A>G | p.Ile71Val | missense_variant | 3/4 | XP_047282522.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FDX1 | ENST00000260270.3 | c.388A>G | p.Ile130Val | missense_variant | 3/4 | 1 | NM_004109.5 | ENSP00000260270 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000650 AC: 99AN: 152196Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000557 AC: 140AN: 251232Hom.: 0 AF XY: 0.000589 AC XY: 80AN XY: 135778
GnomAD4 exome AF: 0.000950 AC: 1389AN: 1461482Hom.: 0 Cov.: 30 AF XY: 0.000919 AC XY: 668AN XY: 727006
GnomAD4 genome AF: 0.000650 AC: 99AN: 152314Hom.: 0 Cov.: 31 AF XY: 0.000604 AC XY: 45AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.388A>G (p.I130V) alteration is located in exon 3 (coding exon 3) of the FDX1 gene. This alteration results from a A to G substitution at nucleotide position 388, causing the isoleucine (I) at amino acid position 130 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at